Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Xiaojuan ShiYi Zhang

Abstract

Cancer testis (CT) antigens are expressed in various types of tumors and represent the potential targets for T cell-based immunotherapy. Analysis of CT gene expression and DNA methylation have indicated that certain CT genes are epigenetically regulated and studies have confirmed that certain CT antigens are regulated by DNA methylation. In this study, we explored the epigenetic regulation of MAGE-A3 and improved the clinical outcome of MAGE-A3-specific T cell therapy in esophageal squamous cell carcinoma (ESCC). We used molecular profiling datasets in The Cancer Genome Atlas to analyze CT gene expression in ESCC and its regulation by DNA methylation. We performed quantitative reverse transcription PCR (qRT-PCR), immunohistochemistry and bisulfite sequencing in ESCC cell lines and ESCC tissues. Functional assays, such as flow cytometry, cytotoxicity assays and ELISA, were performed to determine the demethylation agent, decitabine (5-aza-2'-deoxycytidine, DAC)-treated cancer cell improved antigen specific T cells response. ESCC tumor cell-xenograft mouse model and enzyme-linked immunospot (ELISPOT) assays were used to determine the function of DAC treatment in enhancing anti-MAGE-3 T cell responses in ESCC. Furthermore, we perfo...Continue Reading

References

Nov 7, 1980·Science·A Razin, A D Riggs
Feb 24, 2001·The Annals of Thoracic Surgery·T S WeiserD S Schrump
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shoichiro FujitaMorito Monden
May 11, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre J IssaHagop M Kantarjian
Feb 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier CarrascoDanièle Godelaine
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan Begley, Antoni Ribas
May 12, 2012·CA: a Cancer Journal for Clinicians·John M KirkwoodSoldano Ferrone
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 9, 2013·Nature·Michael J ZillerAlexander Meissner
Jan 25, 2014·Nature Reviews. Cancer·Pierre G CoulieThierry Boon
Oct 16, 2014·Journal for Immunotherapy of Cancer·Seth M PollackCassian Yee
Jan 13, 2015·Expert Review of Clinical Immunology·Xiang LiWeidong Han
Jan 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabrina FichtnerMichael Hundemer
Mar 27, 2015·Science Translational Medicine·Carl H JuneTon N Schumacher
Apr 10, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shinichi KageyamaHiroshi Shiku
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Feb 11, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marjan CruijsenGerwin Huls
Aug 5, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andre KunertReno Debets
Aug 10, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P SaiagP Therasse
Nov 15, 2016·Expert Review of Anticancer Therapy·Joe AbdoSumeet K Mittal
Jul 8, 2018·International Journal of Cancer. Journal International Du Cancer·Xinfeng ChenYi Zhang

❮ Previous
Next ❯

Citations

Aug 15, 2020·Frontiers in Cell and Developmental Biology·Qingyang LeiYi Zhang
Feb 12, 2021·Frontiers in Immunology·Heather F JonesDavid A Scheinberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.